NutriBand Inc.NTRBEarnings & Financial Report
NutriBand Inc. is a healthcare technology firm focused on developing and commercializing innovative transdermal wearable patches, wellness products, and consumer health solutions. Its offerings target areas including nutrition delivery, pain management, and fitness support, serving global consumer healthcare markets across North America and Asia.
NTRB Q3 FY2026 Key Financial Metrics
Revenue
$346.1K
Gross Profit
$68.5K
Operating Profit
$-3.9M
Net Profit
$-3.9M
Gross Margin
19.8%
Operating Margin
-1121.3%
Net Margin
-1119.0%
YoY Growth
-46.4%
EPS
$-0.32
NutriBand Inc. Q3 FY2026 Financial Summary
NutriBand Inc. reported revenue of $346.1K (down 46.4% YoY) for Q3 FY2026, with a net profit of $-3.9M (down 184.2% YoY) (-1119.0% margin). Cost of goods sold was $277.6K, operating expenses totaled $3.9M.
Key Financial Metrics
| Total Revenue | $346.1K |
|---|---|
| Net Profit | $-3.9M |
| Gross Margin | 19.8% |
| Operating Margin | -1121.3% |
| Report Period | Q3 FY2026 |
NutriBand Inc. Annual Revenue by Year
NutriBand Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.1M).
NutriBand Inc. Quarterly Revenue & Net Profit History
NutriBand Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2026 | $346.1K | -46.4% | $-3.9M | -1119.0% |
| Q2 FY2026 | $622.5K | +40.6% | $-2.0M | -321.4% |
| Q1 FY2026 | $667.4K | +63.4% | $-1.4M | -208.1% |
| Q4 FY2025 | $642.4K | +22.4% | $-5.5M | -858.8% |
| Q3 FY2025 | $645.8K | +50.9% | $-1.4M | -211.0% |
| Q2 FY2025 | $442.8K | -32.5% | $-1.7M | -385.1% |
| Q1 FY2025 | $408.5K | -14.3% | $-1.9M | -464.6% |
| Q4 FY2024 | $524.6K | -0.6% | $-1.9M | -358.5% |
Income Statement
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $524613 | $408532 | $442830 | $645796 | $642379 | $667432 | $622452 | $346058 |
| YoY Growth | -0.6% | -14.3% | -32.5% | 50.9% | 22.4% | 63.4% | 40.6% | -46.4% |
Balance Sheet
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $7.5M | $15.2M | $13.6M | $12.5M | $7.5M | $6.2M | $10.2M | $8.4M |
| Liabilities | $1.1M | $1.8M | $1.2M | $1.3M | $1.0M | $1.0M | $1.7M | $870208 |
| Equity | $6.4M | $13.4M | $12.5M | $11.2M | $6.4M | $5.1M | $8.5M | $7.5M |
Cash Flow
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-718240 | $-833926 | $-1.5M | $-1.0M | $-1.2M | $-1.3M | $-1.3M | $-1.8M |